Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
Wave Life Sciences (WVE), a clinical-stage biotechnology company specializing in RNA medicines, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's President and CEO, Paul Bolno, MD, MBA, will deliver a presentation on Monday, January 13, 2025, at 9:45 a.m. PT / 12:45 p.m. ET in San Francisco, CA.
Investors and interested parties can access a live webcast of the presentation through the company's Investor Relations website under the 'Investor Events' section. A replay will be available for a time after the event.
Wave Life Sciences (WVE), un'azienda biotecnologica in fase clinica specializzata in medicinali a base di RNA, ha annunciato la sua partecipazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare. Il Presidente e CEO dell'azienda, Paul Bolno, MD, MBA, terrà una presentazione lunedì 13 gennaio 2025, alle 9:45 PT / 12:45 ET a San Francisco, CA.
Gli investitori e le parti interessate possono accedere a una trasmissione in diretta della presentazione attraverso il sito web delle Relazioni con gli Investitori dell'azienda nella sezione 'Eventi per Investitori'. Una registrazione sarà disponibile per un periodo di tempo dopo l'evento.
Wave Life Sciences (WVE), una compañía biotecnológica en etapa clínica especializada en medicamentos basados en ARN, ha anunciado su participación en la 43ª Conferencia Anual J.P. Morgan Healthcare. El Presidente y CEO de la compañía, Paul Bolno, MD, MBA, realizará una presentación el lunes 13 de enero de 2025, a las 9:45 a.m. PT / 12:45 p.m. ET en San Francisco, CA.
Los inversores y partes interesadas pueden acceder a una transmisión en vivo de la presentación a través del sitio web de Relaciones con Inversores de la compañía en la sección 'Eventos para Inversores'. Una repetición estará disponible por un tiempo después del evento.
웨이브 라이프 사이언스(WVE)는 RNA 의약품을 전문으로 하는 임상 단계의 생명공학 회사로 제43회 JP 모건 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 회사의 회장兼 CEO인 폴 볼노(MD, MBA)가 2025년 1월 13일 월요일 오전 9시 45분 PT / 오후 12시 45분 ET에 샌프란시스코, CA에서 발표를 진행합니다.
투자자 및 관심 있는 당사자는 회사의 투자자 관계 웹사이트에서 '투자자 이벤트' 섹션을 통해 발표의 실시간 웹캐스트에 접근할 수 있습니다. 이벤트 후 일정 시간 동안 재생이 가능합니다.
Wave Life Sciences (WVE), une entreprise de biotechnologie en phase clinique spécialisée dans les médicaments à base d'ARN, a annoncé sa participation à la 43e Conférence Annuelle J.P. Morgan Healthcare. Le Président et CEO de l'entreprise, Paul Bolno, MD, MBA, présentera une conférence le lundi 13 janvier 2025, à 9h45 PT / 12h45 ET à San Francisco, CA.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la présentation via le site web des Relations avec les Investisseurs de l'entreprise dans la section 'Événements pour Investisseurs'. Un replay sera disponible pendant un certain temps après l'événement.
Wave Life Sciences (WVE), ein biopharmazeutisches Unternehmen in der klinischen Phase, das auf RNA-Medikamente spezialisiert ist, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz angekündigt. Der Präsident und CEO des Unternehmens, Paul Bolno, MD, MBA, wird am Montag, den 13. Januar 2025, um 9:45 Uhr PT / 12:45 Uhr ET in San Francisco, CA, eine Präsentation halten.
Investoren und interessierte Parteien können über die Investor Relations-Website des Unternehmens im Bereich 'Investor Events' auf ein Live-Webcast der Präsentation zugreifen. Ein Replay wird nach der Veranstaltung für eine gewisse Zeit verfügbar sein.
- None.
- None.
CAMBRIDGE, Mass., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 13, 2025, at 9:45 a.m. PT / 12:45 p.m. ET.
A live webcast of this presentation can be accessed by visiting “Investor Events” on the Investor Relations section of the Wave Life Sciences website: https://ir.wavelifesciences.com/events-publications/events. A replay of this presentation will be archived and available on the site for a limited time following the event.
About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave’s RNA medicines platform, PRISM®, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave’s diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program in obesity. Driven by the calling to “Reimagine Possible”, Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave’s science, pipeline and people, please visit www.wavelifesciences.com and follow Wave on X (formerly Twitter) and LinkedIn.
Investor Contact:
Kate Rausch
+1 617-949-4827
krausch@wavelifesci.com
Media Contact:
Alicia Suter
+1 617-949-4817
asuter@wavelifesci.com
FAQ
When is Wave Life Sciences (WVE) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Wave Life Sciences' presentation at the J.P. Morgan Healthcare Conference?
Will Wave Life Sciences' J.P. Morgan Healthcare Conference presentation be available for replay?
What is Wave Life Sciences' (WVE) primary focus as a biotechnology company?
